FLG and Alzheimer disease: In this study, when the AD, AR or BA patients were divided into two groups (mild-moderate and severe) based on their severity scores [13–15], both groups showed higher serum levels of filaggrin protein than were observed in healthy controls, but the levels were much greater in the severe patients groups, suggesting the involvement of filaggrin protein in ongoing atopic disorders.